Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
6.7K
Agonism and Antagonism: Quantification01:14

Agonism and Antagonism: Quantification

939
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
939
Combined Effects of Drugs: Antagonism01:30

Combined Effects of Drugs: Antagonism

11.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.5K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.6K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.6K
Drug Discovery: Overview01:26

Drug Discovery: Overview

10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug-Receptor Interaction: Agonist01:25

Drug-Receptor Interaction: Agonist

3.7K
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
3.7K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The Value of Five Novel Anthropometric Indicators in Evaluating MASLD and Liver Fibrosis in MASLD: A Cross-Sectional Study.

JGH open : an open access journal of gastroenterology and hepatology·2026
Same author

The gut commensal Bacteroides thetaiotaomicron harbors prevalent class A and D β-lactamases with cross-taxa dissemination potential.

NPJ biofilms and microbiomes·2026
Same author

CaZAT11 Negatively Fine-Tunes Pepper Immunity to Ralstonia solanacearum by Repressing CaHDZ27.

Plant, cell & environment·2026
Same author

Higher Daytime Light Exposure Predicts Lower Risk of Gastrointestinal Cancer Incidence and Mortality.

International journal of cancer·2026
Same author

Social isolation and 59 common health conditions: insights from observational and genetics analyses.

BMC medicine·2026
Same author

Chaihu Shugan San exerts antidepressant effects in female mice by suppressing hippocampal IL-6 and activating the cAMP-CaMKII-BDNF pathway.

Journal of ethnopharmacology·2026

相关实验视频

Updated: Jan 7, 2026

Diagonal Method to Measure Synergy Among Any Number of Drugs
12:08

Diagonal Method to Measure Synergy Among Any Number of Drugs

Published on: June 21, 2018

19.4K

多模态超图表示学习用于药物协同作用预测.

Zheng Zhang, Tong Luo, Xian-Gan Chen

    IEEE transactions on computational biology and bioinformatics
    |December 29, 2025
    PubMed
    概括

    MHGSynergy是一种新的多模式超图方法,通过分析药物特征和细胞系相互作用,准确预测协同药物组合. 这种方法为发现复杂疾病的新药疗法提供了优势.

    科学领域:

    • 计算生物学是一种计算生物学.
    • 药理学 药理学是指药理学的学科.
    • 生物信息学是一种生物信息学.

    背景情况:

    • 药物联合治疗对于复杂疾病至关重要.
    • 计算方法越来越多地用于药物组合发现.
    • 现有的方法往往忽略了药物和细胞系之间的深层相互作用.

    研究的目的:

    • 引入MHGSynergy,一种用于预测药物协同作用的多式超模图表达式学习方法.
    • 通过结合药物结构,标和物理化学特征来建模协同关系.
    • 通过考虑深层次的相互作用来解决现有方法的局限性.

    主要方法:

    • 使用药物特征作为节点属性构建了三个超图.
    • 使用超图形神经网络来更新药物和细胞系嵌入.
    • 利用一个通道注意力综合融合模块用于表示生成.
    • 开发了药物协同作用分类和回归任务的预测模型.

    主要成果:

    • MHGSynergy 在分类和回归两个基准数据集上表现强.
    • 在预测药物协同作用方面表现优于现有的基线方法.
    • 在预测未知的药物对或细胞系的协同作用方面展示了独特的优势.

    更多相关视频

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    12.5K
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.5K

    相关实验视频

    Last Updated: Jan 7, 2026

    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    19.4K
    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
    07:51

    High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method

    Published on: May 21, 2018

    12.5K
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.5K

    结论:

    • MHGSynergy是一个有价值的计算工具,用于发现协同作用的药物组合.
    • 该方法有效地模拟复杂的药物细胞系相互作用.
    • 为推进药物组合治疗研究提供了一个有前途的途径.